Spine

ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State

Retrieved on: 
Tuesday, March 5, 2024

NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania.

Key Points: 
  • NSG is a free-standing, privately-owned clinic serving Central New York, the New York Southern Tier, and Northern Pennsylvania.
  • System installation is expected to begin in July, with first patient treatments estimated to commence before the end of the year.
  • “As a procedure with no incisions and no pain, ZAP-X radiosurgery treats patients in what often requires only a single brief outpatient visit.
  • This novel approach aims to maximally safeguard healthy brain tissue and preserve patient cognitive function.

Orthofix Announces New President for Bone Growth Therapies Business

Retrieved on: 
Thursday, February 29, 2024

(NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Jason Shallenberger to President of the Bone Growth Therapies business, and the realignment of its Spine business unit, effective March 1.

Key Points: 
  • (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Jason Shallenberger to President of the Bone Growth Therapies business, and the realignment of its Spine business unit, effective March 1.
  • Sales and Marketing for the Orthofix Bone Growth Therapies business.
  • View the full release here: https://www.businesswire.com/news/home/20240229167353/en/
    Orthofix names Jason Shallenberger as President, Bone Growth Therapies (Photo: Business Wire)
    Prior to this realignment, the Bone Growth Therapies business was managed under the leadership of the Company’s Spine business unit.
  • Bone Growth Therapies and Spine will now be led by separate Presidents in alignment with the Company’s current business structures for Biologics and Enabling Technologies.

Spinal Non-Fusion Devices Market Poised for Growth: Global Insights and Forecast to 2030 - Escalating Prevalence of Spinal Disorders, Advanced Product Options, and Product Developments - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 27, 2024

The "Spinal Non-Fusion Devices Market Insights, Competitive Landscape and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Spinal Non-Fusion Devices Market Insights, Competitive Landscape and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
  • According to a detailed market assessment, the Spinal Non-Fusion Devices sector was valued at a commendable USD 2,757.17 million in the year 2023.
  • The expected growth trajectory is attributed to the escalating prevalence of spinal disorders, advanced product options, and burgeoning product development endeavors.
  • With specialized segmentation ranging from product type to global geography, this comprehensive market assessment elucidates the dynamic environment of the Spinal Non-Fusion Devices market.

Roha Medical Campus, a World-Class Hospital in Ethiopia, Gets $42 Million First Injection

Retrieved on: 
Thursday, February 22, 2024

The equity funding represents the first tranche of a US$130 million investment to build phase 1 of Roha Medical Campus, a 350-bed world-class hospital.

Key Points: 
  • The equity funding represents the first tranche of a US$130 million investment to build phase 1 of Roha Medical Campus, a 350-bed world-class hospital.
  • Designed to be Ethiopia’s first JCI-accredited1 hospital, Roha Medical Campus will alleviate an acute shortage of advanced medical facilities and healthcare services for Africa’s second largest nation and patients in the region.
  • “Ethiopian Airlines’ global connectivity strengthens the case for medical tourism and ensures strong US dollar revenue for the hospital.
  • Roha Medical Campus will reduce costs and increase accessibility relative to other local hospitals and comparable international medical tourism packages.

joimax® Expands Distribution in Italy – Announces New Partnership with Uber Ros S.p.A

Retrieved on: 
Wednesday, February 21, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240221579002/en/
    Kick-off meeting and first training session with the Uber Ros team, held February 15-16 at the joimax® Karlsruhe headquarters.
  • (Photo: Business Wire)
    Under this strategic alliance, Uber Ros will be a full sales and service provider of joimax® products to surgeons and medical practitioners throughout Italy.
  • “We’re looking forward to working with Uber Ros, a strong and well-established partner in Italy,” says joimax® Founder and CEO Wolfgang Ries.
  • “Uber Ros and joimax® will align all education activities and set-up special workshop programs that offer certified courses to Italian physicians,” says ESPINEA® Chairman Wolfgang Ries.

Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024

Retrieved on: 
Wednesday, February 21, 2024

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024 after market close.

Key Points: 
  • Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it will release its fourth quarter and full year 2023 financial results on Tuesday, March 5, 2024 after market close.
  • The Company will host a conference call and webcast to review results at 4:30 p.m.
  • Interested parties may access the conference call by dialing (888) 330-2508 in the U.S., and (240) 789-2735 in all other locations, and referencing the event passcode 9556380.
  • A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com .

Movella and DIERS Announce 'Free2Move' Healthcare Technology for Objective Patient Assessment

Retrieved on: 
Tuesday, February 20, 2024

Together the company will release free²move: a new healthcare technology designed to seamlessly integrate into traditional clinical settings and enable patient testing beyond the limitations of traditional laboratory settings.

Key Points: 
  • Together the company will release free²move: a new healthcare technology designed to seamlessly integrate into traditional clinical settings and enable patient testing beyond the limitations of traditional laboratory settings.
  • By providing objective, validated data that meets rigorous healthcare industry standards, this solution enables healthcare professionals to objectively evaluate individuals and achieve more accurate and insightful patient assessments.
  • View the full release here: https://www.businesswire.com/news/home/20240220855658/en/
    Movella and DIERS have joined forces to revolutionize healthcare testing, offering certified protocols and unmatched accuracy.
  • Noteworthy for its emphasis on objective testing, diagnosis, and adherence to treatment protocols, DIERSfree²move introduces a nuanced approach to healthcare technology, prioritizing accuracy and reliability in patient assessment and care.

MedHQ Announces Featured Speakers and 2024 Programming

Retrieved on: 
Thursday, March 7, 2024

WESTCHESTER, Ill., March 7, 2024 /PRNewswire/ -- MedHQ, a leading provider of technology-enabled expert services to hospitals, outpatient clinics, physician groups, and ambulatory surgery centers, announces a full lineup up speaking engagements, trade shows and programming throughout 2024.

Key Points: 
  • WESTCHESTER, Ill., March 7, 2024 /PRNewswire/ -- MedHQ, a leading provider of technology-enabled expert services to hospitals, outpatient clinics, physician groups, and ambulatory surgery centers, announces a full lineup up speaking engagements, trade shows and programming throughout 2024.
  • MedHQ had a presence at two events in February including the Healthcare Summit at Jackson Hole, and the American Academy of Orthopaedic Surgeons (AAOS) 2024 Annual Meeting.
  • Miller will be a featured speaker at the Chief Human Resources Officer + Workforce Forum on Tuesday, April 9, 2024, during the Annual Meeting.
  • In September, MedHQ will be attending the Physician-led Healthcare for America (PHA) 2024 Leadership Summit.

EmergeOrtho--Triangle Region Welcomes Dr. Ryan McCarter

Retrieved on: 
Monday, March 4, 2024

DURHAM, N.C., March 4, 2024 /PRNewswire/ -- EmergeOrtho—Triangle Region welcomes Dr. Ryan McCarter, a highly esteemed Physical Medicine and Rehabilitation specialist, focusing on Interventional Spine and Musculoskeletal Medicine.

Key Points: 
  • DURHAM, N.C., March 4, 2024 /PRNewswire/ -- EmergeOrtho—Triangle Region welcomes Dr. Ryan McCarter, a highly esteemed Physical Medicine and Rehabilitation specialist, focusing on Interventional Spine and Musculoskeletal Medicine.
  • "I'm excited to join the EmergeOrtho team and contribute to the mission of delivering top-tier orthopedic and musculoskeletal care," said Dr. McCarter.
  • "As a physician, my goal is to empower each patient on their journey to recovery," said Dr. McCarter.
  • To seek pain treatment, schedule an appointment with Dr. Ryan McCarter.

Kleiner Device Labs Presents e-Poster at Southern Neurosurgical Society Meeting: "Rethinking Posterior MIS Fusion - Enabling Risk Reduction in Posterior Spinal Surgery"

Retrieved on: 
Thursday, February 29, 2024

INCLINE VILLAGE, Nev., Feb. 29, 2024 /PRNewswire/ -- Kleiner Device Labs (KDL) today announced that an e-Poster has been accepted for the Southern Neurosurgical Society's 2024 annual conference beginning on March 7 in Orlando.

Key Points: 
  • INCLINE VILLAGE, Nev., Feb. 29, 2024 /PRNewswire/ -- Kleiner Device Labs (KDL) today announced that an e-Poster has been accepted for the Southern Neurosurgical Society's 2024 annual conference beginning on March 7 in Orlando.
  • Dr. Blake Burkert, of NeuroSpine Group, Eugene, Oregon, noted, "I share those concerns and want to minimize risks in my own OR.
  • The company will attend the meeting and looks forward to demonstrating the new KG®2 Surge® flow-thru interbody system to surgeons.
  • The e-Poster presentation will be available at the meting and afterwards on the company's web site.